Driving Naari Programme launched in Chandigarh
Bharat Biotech said on Wednesday it had submitted data from its Covid-19 vaccine trial in children aged 2 to 18 years to India’s drug regulator, becoming the country’s first company to have tested its shot in very young children.
India is turning its focus towards vaccinating children against the coronavirus, having already administered more than 920 million doses to adults among its population of nearly 1.4 billion.
India’s drug regulator last month allowed vaccine maker Serum Institute to enrol kids aged 7 to 11 years for its trial of US drugmaker Novavax’s Covid-19 vaccine.
So far, only drugmaker Zydus Cadila’s DNA-based Covid-19 vaccine has received emergency use approval in India to be used in adults and children aged at least 12 years.
